✦ LIBER ✦

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor alogliptin added to pioglitazone in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study*

✍ Scribed by Pratley, Richard E.; Reusch, Jane E.-B.; Fleck, Penny R.; Wilson, Craig A.; Mekki, Qais

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of adding the dipept

✍ M. A. Nauck; G. C. Ellis; P. R. Fleck; C. A. Wilson; Q. Mekki; for the Aloglipti 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Pharmacokinetic, pharmacodynamic, and to

✍ Paul Covington; Ronald Christopher; Michael Davenport; Penny Fleck; Qais A. Mekk 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 253 KB

Efficacy and safety of alogliptin added

✍ K. Kaku; T. Itayasu; S. Hiroi; M. Hirayama; Y. Seino 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

Efficacy and safety of the dipeptidyl pe

✍ R. E. Pratley; M. S. Kipnes; P. R. Fleck; C. Wilson; Q. Mekki; Alogliptin Study 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB

Efficacy and safety of alogliptin added

✍ Y. Seino; Y. Miyata; S. Hiroi; M. Hirayama; K. Kaku 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Efficacy and safety of alogliptin added

✍ Seino, Yutaka; Hiroi, Shinzo; Hirayama, Masashi; Kaku, Kohei 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 270 KB